Contents
Premium Noble Kava
Entdecken Sie zertifizierte Qualität und Reinheit bei unserem offiziellen Partner.
Zu Kava-mode.comBrief & Concise
Kava has a high potential for drug interactions due to the inhibition of cytochrome P450 enzymes. Never combine Kava with:
- ●Alcohol – Increased sedation and liver toxicity
- ●Benzodiazepines – Risk of respiratory depression
- ●Antipsychotics – Increased sedation, movement disorders
- ●Anticoagulants – Risk of bleeding
The Cytochrome P450 System
The cytochrome P450 system (CYP450) is a family of enzymes in the liver responsible for the metabolism of most medications. When a substance inhibits these enzymes, other substances are metabolized more slowly – their effects and side effects can therefore be amplified.
Why is this important?
About 70-80% of all medications are metabolized by CYP450 enzymes. When Kava inhibits these enzymes, the concentration of other medications in the blood can increase – sometimes to dangerous levels. This is especially true for medications with a narrow therapeutic window, where small changes in dosage can have significant effects.
Which enzymes are inhibited?
Studies by Mathews et al. (2002) and other researchers have shown that Kavalactones inhibit several important CYP450 enzymes:
| Enzyme | Inhibition Strength | Important Substrates (Examples) |
|---|---|---|
| CYP1A2 | Strong | Caffeine, Theophylline, Clozapine, Olanzapine |
| CYP2C9 | Strong | Warfarin, Phenytoin, NSAIDs (Ibuprofen) |
| CYP2C19 | Moderate | Omeprazole, Diazepam, Clopidogrel |
| CYP2D6 | Moderate | Codeine, Tramadol, many antidepressants |
| CYP3A4 | Strong | Benzodiazepines, Statins, many antibiotics |
Clinical Significance
A study by Russmann et al. (2005) showed that traditional aqueous Kava extracts also inhibit CYP1A2 in humans. The inhibition was dose-dependent and clinically relevant. This means that even traditionally prepared Kava can cause interactions.
High-Risk Combinations
The following combinations should be avoided at all costs. They can lead to severe, potentially life-threatening side effects.
⚠ Alcohol
Risiko: VERY HIGH
The combination of Kava and alcohol is particularly dangerous for several reasons:
- 1.Synergistic Sedation: Both substances have a sedative effect on the CNS. The combined effect is stronger than the sum of the individual effects.
- 2.Additive Hepatotoxicity: Both substances are metabolized in the liver and can burden it. The combination significantly increases the risk of liver damage.
- 3.CYP Interaction: Alcohol also affects CYP enzymes, which can lead to unpredictable interactions.
Recommendation: At least 24 hours between alcohol and Kava consumption.
⚠ Benzodiazepines & Sleep Medications
Risiko: VERY HIGH
Benzodiazepines (Diazepam, Lorazepam, Alprazolam, etc.) and Z-Drugs (Zolpidem, Zopiclone) should never be combined with Kava:
- •Increased Sedation: Both act on GABA receptors and enhance each other
- •Respiratory Depression: The combination can dangerously slow down breathing
- •CYP3A4 Inhibition: Kava slows the metabolism of benzodiazepines, prolonging their effect
Case Report: Almeida & Grimsley (1996) reported on a 54-year-old man who fell into a semi-comatose state after combining Kava with Alprazolam.
⚠ Antipsychotics
Risiko: HIGH
Antipsychotics such as Haloperidol, Risperidone, Olanzapine, and Clozapine:
- •Increased Sedation: Additive CNS depressant effect
- •Extrapyramidal Symptoms: Increased risk of movement disorders
- •CYP1A2/CYP2D6 Inhibition: Slowed metabolism, higher blood levels
⚠ Anticoagulants (Blood Thinners)
Risiko: HIGH
Warfarin and other vitamin K antagonists:
- •CYP2C9 Inhibition: Kava inhibits the enzyme that metabolizes Warfarin
- •Increased INR: Increased tendency to bleed
- •Risk of Bleeding: Can lead to dangerous internal bleeding
Kava is contraindicated when taking anticoagulants.
Combinations with Moderate Risk
The following combinations require caution and should only be undertaken after consulting a physician. A dosage adjustment may be necessary.
Antidepressants
Risiko: MODERATE
- • CYP2D6 inhibition may slow metabolism
- • Theoretical risk of serotonin syndrome (low)
- • Increased sedation possible
- • Similar interactions as SSRIs
- • CYP2D6 inhibition relevant for Venlafaxine
- • Kava inhibits MAO-B (weakly) via kavalactones
- • <strong>New (2026):</strong> Flavokawain A has been identified as a potent MAO-A inhibitor (IC50: 0.077 µM, Pawa et al., 2026). This significantly increases the theoretical risk of an interaction with MAO inhibitors.
- • Special caution with irreversible MAO inhibitors (Tranylcypromine, Phenelzine)
- • The combination of Kava with MAO inhibitors should be avoided until further clinical data is available
Anticonvulsants (Antiepileptics)
Risiko: MODERATE
Phenytoin, Carbamazepine, Valproate, and other anticonvulsants:
- •CYP Interactions: Altered blood levels possible
- •Increased Sedation: Additive CNS effect
- •Seizure Control: May be impaired
In epilepsy, Kava should only be used under medical supervision.
Parkinson's Medications
Risiko: MODERATE to HIGH
Levodopa and dopamine agonists:
- •Dopamine Antagonism: Kava may reduce the effect of Levodopa
- •Case Report: Worsening of Parkinson's symptoms documented under Kava
Kava is contraindicated in Parkinson's disease.
Hepatotoxic Medications
Risiko: MODERATE
Medications with known hepatotoxic potential:
- •Paracetamol/Acetaminophen: Especially problematic at higher doses
- •Statins: Atorvastatin, Simvastatin, etc. (CYP3A4 substrates)
- •Methotrexate: Immunosuppressant with hepatotoxicity
- •Isoniazid: Tuberculosis medication
Combining with hepatotoxic medications increases the risk of liver damage.
Overview Table of Interactions
| Substance Class | Examples | Risk | Mechanism |
|---|---|---|---|
| Alcohol | Ethanol | VERY HIGH | Synergistic sedation, hepatotoxicity |
| Benzodiazepines | Diazepam, Lorazepam, Alprazolam | VERY HIGH | GABA enhancement, CYP3A4 inhibition |
| Antipsychotics | Haloperidol, Olanzapine, Clozapine | HIGH | CYP1A2/2D6 inhibition, sedation |
| Anticoagulants | Warfarin, Phenprocoumon | HIGH | CYP2C9 inhibition, bleeding risk |
| SSRIs | Fluoxetine, Sertraline, Paroxetine | MODERATE | CYP2D6 inhibition |
| Anticonvulsants | Phenytoin, Carbamazepine | MODERATE | CYP interactions, sedation |
| Parkinson's Medications | Levodopa, Dopamine Agonists | MODERATE | Dopamine antagonism |
| Statins | Atorvastatin, Simvastatin | MODERATE | CYP3A4 inhibition, hepatotoxicity |
| Opioids | Codeine, Tramadol, Morphine | MODERATE | CYP2D6 inhibition, sedation |
| Caffeine | Coffee, Energy Drinks | LOW | CYP1A2 inhibition (prolonged effect) |
Practical Recommendations
Checklist Before Kava Consumption
- 1.Check Medication List
Review all current medications for interactions
- 2.Consult a Doctor
Seek medical advice before Kava consumption if taking medications regularly
- 3.Avoid Alcohol
Do not drink alcohol at least 24 hours before and after Kava consumption
- 4.Dose Low
Start with a lower Kava dose when taking medications simultaneously
- 5.Monitor Symptoms
Watch for unusual fatigue, dizziness, or other symptoms
Continue in the Safety Chapter
Based on studies by
With contributions from
This wiki is a curated resource that synthesizes research from peer-reviewed studies and expert researchers. It is not written by the researchers listed above, but rather based on their published work.
Scientific Sources
The information on this page is based on the following scientific studies and publications:
Cytochrome P450 2E1 (CYP2E1) Is the Principal Enzyme Responsible for Urethane Metabolism
Hoffler U., El-Masri H.A., Ghanayem B.I. (2003) – Journal of Pharmacology and Experimental Therapeutics
View studyContents
Premium Noble Kava
Entdecken Sie zertifizierte Qualität und Reinheit bei unserem offiziellen Partner.
Zu Kava-mode.com
common:ui.bookTitle
common:ui.bookDescription